| valsartan / Generic mfg. |
2004-003235-31: Effect of pravastatin or fluvastatin and add-on valsartan on inflammatory markers and peripheral endothelial function in patients with acute coronary syndrome |
|
|
| Ongoing | 4 | 80 | Europe | Lescol, Diovan, PRAVASTATIN "RATIOPHARM", Tablet, Lescol, Diovan, PRAVASTATIN "RATIOPHARM" | Div. of Cardiology, Innsbruck Medical University | Acute coronary syndrome; patients with NSTEMI | | | | |
ChiCTR-TRC-10001071: The Effect of Amlodipine and Valsartan in Hypertensive Renal Post-transplant Patients |
|
|
| Completed | 4 | 150 | | amlodipine(Norvase, 5mg/tablet) + metoprolol(Betaloc,12.5mg/tablet) ;valsartan(Diovan, 80mg/tablet) +metoprolol(Betaloc,12.5mg/tablet) | the Third Xiangya Hospital of Central South University; Hunan Science and Technology Bureau, Science and Technology Program of Hunan (2006SK2003) | Post-transplant hypertension | | | | |
ChiCTR-TRC-12004443: The Infect of Olmesartan on Atrial Fibrillation Load in Patients with Sick Sinus Syndrome |
|
|
| Completed | 4 | 120 | | Valsartan ;Placebo | Nanjing First Hospital Department Of Cardiology; Nanjing First Hospital Department Of Cardiology, self-raised | Sick Sinus Syndrome | | | | |
ChiCTR-IPR-14005368: Prospective trial of leflunomide in the treatment of immunoglobulin A nephropathy |
|
|
| Not yet recruiting | 4 | 60 | | leflunomide 20mg/d ;Valsartan 80mg/d | West China Hospital of Sichuan University; Level of the institution：, Funding Opportunity | immunoglobulin A nephropathy | | | | |
ChiCTR-TRC-12002642: Upstream Therapeutic Strategies of Valsartan and Fluvastatin on Hypertension Patients with Non-chronic Atrial Fibrillation |
|
|
| Completed | 4 | 2000 | | Valsartan ;fluvastatin & CCB ;valsartan & fluvastatin ;CCB | The second hospital of Tianjin Medical University; Level of the institution：, Unit self-finance, financial appropriation | Hypertension Patients with Atrial Fibrillation | | | | |
2004-001270-77: Estudio piloto para evaluar la eficacia y seguridad de Valsartán para el control de la progresión de la insuficiencia renal y la morbimortalidad cardiovascular en pacientes con trasplante renal funcionante con proteinuria e insuficiencia renal leve o moderada. |
|
|
| Ongoing | 4 | 178 | Europe | Diovan, HIPOTENSORES, DIURETICOS, VASODILATADORES PERIFÉRICOS, BETABLOQUEANTES, CALCIO ANTAGONISTAS, C02, C03, C04, C07, C08, DIOVAN, DIOVAN | Equipo de doctores: Dr. Amado Andrés y Dr. Manuel Praga | Pacientes varones y mujeres de 18 a 70 años con trasplantes renales funcionantes de más de 1 año de evolución y una insuficiencia renal leve o moderada (creatinina sérica > 1,3 mg/dl en mujeres y > 1,5 mg/dl en varones y < 3 mg/dl en ambos casos) y proteinuria (>0,5 g/24 h y < 3,5 g/24 h). | | | | |
2006-000523-34: Intensiv ikke-sympatikus aktiverende vasodilaterende behandling hos patienter med mikrovaskulær angina pectoris |
|
|
| Ongoing | 4 | 115 | Europe | Zanidip, Diovan, Doxazosin \"Stada\", Moxonidin \"Alpharma\", Visken, Sparkal, Selo-Zok, Myonil Retard, Isodur, Centyl med kaliumchlorid, Angicor, Zanidip, Diovan, Doxazosin \"Stada\", Moxonidin \"Alpharma\", Visken, Sparkal, Selo-Zok, Myonil Retard, Isodur, Centyl med kaliumchlorid, Angicor | Århus Sygehus | Patienter med hypertension og angina pectoris og ingen signifikante stenoser ved koronararteriografi (KAG). | | | | |
2006-003473-27: Wirkung von Telmisartan 80 mg im Vergleich zu Valsartan 160 mg auf die Insulinsensitivität (HOMA) - WITEVA - |
|
|
| Ongoing | 4 | 40 | Europe | Diovan / Kinzal, BAY69-9291, Diovan 80/160 Kinzal 40/80, Diovan 80/160 Kinzal 40/80 | MedQuality Forschung GmbH | Hypertension | | | | |
2006-006719-66: Efficacité d’un traitement par l’association amlodipine et valsartan en monoprise vespérale ou matinale, chez des Patients présentant une HTA Essentielle moyenne à modérée, non contRôlée par amlodipine 5mg en mesure ambulatoire de la pression arTérielle: Etude ExPERT |
|
|
| Ongoing | 4 | 45 | Europe | Tareg, Amlor, Tareg, Amlor, Tareg, Amlor | Novartis Pharma S.A.S. | HTA essentielle | | | | |
2008-000804-10: Valsartan 160 mg and hydrochlorothiazide 25 mg in subject suffering from arterial hypertension stage 1 or high normal with organ damage |
|
|
| Ongoing | 4 | 20 | Europe | CORIXIL, CORIXIL | UNIVERSITA, DEGLI STUDI DI NAPOLI FEDERICO II | Arterial Hypertension with organ damage | | | | |
2007-007482-21: Multi-center, Open-label Study of the Safety and Efficacy of Control of Proteinuria with ACE Inhibitors and ARBS in Patients with Fabry Diseaswe Who Are receiving Farazyme : Tha Farazyme + Arbs + ACE inhibitors Treatments (FAACET) Study: The FAACET Study |
|
|
| Ongoing | 4 | | Europe | perdix, ZESTORIC, innozide, lisinopril, zestril, coversyl, coversyl PLUS, Accupro, Accuretic, lopace, triapin& triapin Mite, rampril, tritace, gopten, carace, Staril, acepril, CAPOZIDE, AMIAS, TEVETON, aprovel, 0lmetec, micardis, Co Diovan, perdix, Zestoretic 10,20, INNOZIDE, lisinopril, zestril, coversyl, coversyl PLUS, Accupro, Accuretic, lopace, triapin, RAMPRIL, TRITACE, GOPTEN, carace, Staril, Acepril, CAPOZIDE, CAPOTEN, AMIAS, TEVETEN, aprovel, olmetec, micardis, Co Diovan, perdix, Zestoretic 10,20, INNOZIDE, lisinopril, zestril, coversyl, coversyl PLUS, Accupro, Accuretic, lopace, triapin, RAMPRIL, TRITACE, GOPTEN, carace, Staril, Acepril, CAPOZIDE, CAPOTEN, AMIAS, TEVETEN, aprovel, olmetec, micardis, Co Diovan | Salford Royal NHS Foundation Trust | Fabry disease with proteinuria. | | | | |
2016-002897-10: Determination of drug amounts in the duodenum with the help of a catheter Bepaling van de hoeveelheid geneesmiddelen in de darm met behulp van een katheter. |
|
|
| Ongoing | 4 | 5 | Europe | Perdolan, Clamoxyl, Diovane, Syrup, Tablet, Perdolan, Clamoxyl, Diovane | KU Leuven - Drug Delivery and Disposition, KU Leuven | Healthy human volunteers, investigation of free drug concentrations in the duodenum Gezonde vrijwilligers, onderzoek naar vrije concentraties in de darm, Healthy human volunteers, investigation of free drug concentrations in the duodenum Gezonde vrijwilligers, onderzoek naar vrije concentraties in de darm, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10] | | | | |
2017-000213-23: Dual treatment for patients with chronic kidney disease, high blood pressure and diabetes. Combinatiebehandeling voor chronische nierschade bij hoge bloeddruk en diabetes. |
|
|
| Ongoing | 4 | 31 | Europe | Tablet, Entresto, Valsartan | | Chronic kidney disease with concurrent hypertension and diabetes. Chronische nierinsufficientie bij hypertensie en diabetes mellitus., Chonic kidney disease with concurrent high blood pressure and diabetes. Chronische nierschade bij hoge bloeddruk en suikerziekte., Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02] | | | | |
2017-003672-31: Fixed-dose combination of rosuvastatin and valsartan for dual target achievement in patients with hypertension and hyperlipidaemia (UNIFY) |
|
|
| Not yet recruiting | 4 | 280 | Europe | Ravalsyo, Film-coated tablet, Ravalsyo® | KRKA, d.d., Novo mesto, KRKA d.d., Novo mesto | Patients with mild to moderate essential arterial hypertension AND primary hypercholesterolemia or mixed dyslipidaemia (LDL-c < 4.9 mmol/L or <189.5 mg/dl) with moderate, high or very high risk for cardiovascular event., Patients with mild to moderate essential arterial hypertension AND primary hypercholesterolemia or mixed dyslipidaemia with moderate, high or very high risk for cardiovascular event., Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2018-003936-62: VALSARTAN TREATMENT COMPARED IN RENAL TRANSPLANT RECIPIENTS WITH SIGNS OF POST TRANSPLANT GLOMERULOPATHY TRATAMIENTO CON VALSARTÁN EN PACIENTES TRASPLANTADOS RENALES CON SIGNOS DE GLOMERULOPATÍA POST TRASPLANTE |
|
|
| Not yet recruiting | 4 | 180 | Europe | Tablet | HOSPITAL UNIVERSITARI DE BELLVITGE-IDIBELL, INSTITUTO DE SALUD CARLOS III | POST TRANSPLANT RENAL GLOMERULOPATHY GLOMERULOPATÍA RENAL POST TRASPLANTE, CHRONIC RENAL IMPAIRMENT AFTER RENAL TRANSPLANTATION DAÑO RENAL CRÓNICO TRAS EL TRASPLANTE RENAL, Body processes [G] - Immune system processes [G12] | | | | |
ChiCTR1800019346: Evaluation of the bioequivalence of Valsartan Capsules 80 mg on fasting and fed conditions |
|
|
| Recruiting | 4 | 84 | | 1 capsule was dosed in each cycle/each subject, total 3 cycles. ;1 capsule was dosed in each cycle/each subject, total 3 cycles. | First Hospital of Jilin University; First Hospital of Jilin University, China Resources Saike Pharmaceutical Co.,Ltd. | mild to moderate essential hypertension | | | | |
ChiCTR1800015649: New active element (rhBNP) sequential sand kubah song/valsartan (LCZ696) in the treatment of acute heart failure study |
|
|
| Not yet recruiting | 4 | 300 | | base treament ;rhBNP combine base treatment ;rhBNP combine LCZ696 | Tianjin Union Medical Center; Tianjin Union Medical Center, self-raised | acute heart failure | | | | |
ChiCTR1900025506: Clinical observation of Sacrubitril/Valsartan in the treatment of heart failure |
|
|
| Recruiting | 4 | 300 | | use Sacrubitril /valsartan ;use ACEI | China-Japan Union Hospital of Jilin Universuty; China-Japan Union Hospital of Jilin University, Jilin Province Key Laboratory of Cardiovascular Disease Genetic Diagnosis | heart failure | | | | |
2021-001327-41: Withdrawal of pharmacological treatment in patients responding to cardiac resynchronization therapy: Open and randomized study Retirada de tratamiento farmacologico en pacientes respondedores a terapia de resincronización cardiaca: Estudio abierto y aleatorizado |
|
|
| Ongoing | 4 | 60 | Europe | furosemide, bisoprolol, Coated tablet, Furosemide, Bisoprolol, Eplerenone, Valsartan | Fundación para la formación e investigación sanitarias de la Región de Murcia, ISCarlos III | Heart failure Insuficiencia cardiaca, Heart failure Insuficiencia cardiaca, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
ChiCTR1900024752: Clinical Study for Intensive Glucose Control Combined With Double RAS Inhibitory Therapy for Type 2 Diabetic Nephropathy |
|
|
| Recruiting | 4 | 120 | | Intensive insulin therapy+Valsartan capsule 80mg + perindopril tert-butylamine tablets 4mg 1/day ;Intensive insulin therapy+Valsartan capsule160mg 1/day ;Intensive insulin therapy+perindopril tert-butylamine tablets 8mg 1/day | Nephrology Division, the First Hospital Affiliated to Army Medical University; The First Hospital Affiliated to Army Medical University, Chongqing Science and Health Joint Medical Research Project | Type 2 Diabetic Nephropathy | | | | |
ChiCTR1900028468: Efficacy and safety of sacurabatril valsartan in patients with heart failure and renal insufficiency |
|
|
| Recruiting | 4 | 120 | | Treatment with ARNI ;Treatment with Valsartan | The First Central Hospital of Tianjin; First Central Hospital of Tianjin, Self-raised | Chronic Heart Failure and Chronic kidney disease（CKD）stage 1-3 | | | | |
ChiCTR2100043953: A study of Sacubatril/valsartan in improving prognosis of uremia patients with heart failure on peritoneal dialysis |
|
|
| Recruiting | 4 | 60 | | Sacubatril/valsartan | Department of Nephrology, General Hospital of Ningxia Medical University; Department of Nephrology, General Hospital of Ningxia Medical University, Funding for other scientific research projects | Uremia peritoneal dialysis with heart failure | | | | |
MRA-ACE, NCT03502031: Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy |
|
|
| Recruiting | 4 | 72 | US | Renin-Angiotensin (RAAS) alone, Lispril, Enalapril, Perindopril, Losarta, Valsar etc.,, Renin-Angiotensin (RAAS) blockers in combination with Spironolactone, Lisinopril, Enalapril, Perindopril, Losartan, Valsartan, or Spironolactone | James A. Tumlin, MD, Nelson Kopyt, MD | Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2 | 10/22 | 10/24 | | |
ChiCTR2200062762: Clinical study of valsartan reducing the incidence of grade 2 or higher radiation pneumonitis after thoracic radiotherapy |
|
|
| Not yet recruiting | 4 | 60 | | valsartan | Ji'nan Central Hospital; Ji'nan Central Hospital, Scientific research funding of Oncolgy department ，Jinan Central Hospital | lung cancer | | | | |
ChiCTR2000034557: The effect of Chinese herbal medicine Shugan Wendan Decoction for the treatment of H-type essential hypertension: a ranodmized controlled trial. |
|
|
| Not yet recruiting | 4 | 90 | | Valsartan (80mg, po, q.d.) ;Valsartan capsules, 80mg, po q.d.+ Shugan Wendan soup, po, q.d. | Guangdong Provincial Hospital of Traditional Chinese Medicine; Guangdong Provincial Hospital of traditional Chinese Medicine, Self-raised | H-type essential hypertension | | | | |
| Not yet recruiting | 4 | 68 | NA | Valsartan, Novartis | Fifth Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University | Hypertension;Nephropathy | 06/23 | 12/23 | | |
NCT04769778: Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine |
|
|
| Recruiting | 4 | 180 | Europe | Valsartan 80Mg Oral Tablet | Josep M Cruzado | Chronic Kidney Allograft Nephropathy | 06/23 | 06/23 | | |
NCT05269615: Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II |
|
|
| Recruiting | 4 | 80 | RoW | Valsartan 80 mg, Placebo | The University of Hong Kong | Exercise Physiology | 09/24 | 09/24 | | |
NCT05095922: Effect of HMP on Diabetic Microangiopaemia in T2DM |
|
|
| Completed | 4 | 40 | RoW | Heart-Protecting Musk Pill, Heart-Protecting Musk Pill，National Medicine Permission Number Z31020068，86900674000453, Valsartan Capsules, Valsartan Capsules，National Medicine Permission Number H20040217，86900100000095, Calcium Dobesilate Capsules, Doxium，H20140641 | Affiliated Hospital of Nantong University | Diabetes Mellitus, Type 2, Diabetic Angiopathies | 05/24 | 05/24 | | |
ChiCTR2000035327: Comparison of ARNI and ARB in the treatment of elderly patients with acute decompensated ejection fraction preserved heart failure |
|
|
| Not yet recruiting | 4 | 40 | | ARNI 24/26mg bid;49/51mg bid;97/103mg bid ;ARB 40mg bid;80mg bid;160mg bid | Shanghai General Hospital; Shanghai General Hospital, self-raised | heart failure | | | | |
NCT03938389: The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans |
|
|
| Active, not recruiting | 4 | 90 | US | Sacubitril-Valsartan Tab 97-103 MG, Entresto, Valsartan 160mg, Diovan, Placebo Oral Tablet | Ohio State University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | PreDiabetes, Impaired Glucose Tolerance, Obesity, Blood Pressure | 02/24 | 06/25 | | |
| Recruiting | 4 | 130 | Europe | Perindopril, Valsartan | Academisch Ziekenhuis Maastricht, ZonMw: The Netherlands Organisation for Health Research and Development | Heart Failure, Diastolic Dysfunction | 03/26 | 03/26 | | |
NCT03738878: Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1 |
|
|
| Active, not recruiting | 4 | 32 | US | Valsartan, LCZ696, Entresto, Bradykinin, Substance P, BNP, Nesiritide, Sitagliptin, Januvia | Vanderbilt University Medical Center | Hypertension | 07/25 | 12/25 | | |
ChiCTR2300068678: A single-center, randomized, prospective clinical study of Azisartan versus valsartan in the treatment of post-infarction ventricular remodeling in patients with diabetes after STEMI |
|
|
| Not yet recruiting | 4 | 240 | | Azisartan 20-40mg orally ;Valsartan 80-160mg orally | The People’s Hospital of Liaoning Province; The People’s Hospital of Liaoning Province, Supported by Xinxin Cardiovascular Health Foundation | Acute myocardial infarction | | | | |
ChiCTR2300076082: A single-center randomized crossover controlled trial to evaluate the efficacy and safety of azisartan in the treatment of proteinuria and renal function in non-dialytic hypertensive patients with IgA nephropathy |
|
|
| Not yet recruiting | 4 | 302 | | The first 12 weeks after taking azilsartan to valsartan; After taking valsartan in the first 12 weeks, it was changed to azilsartan. | Chinese Cardiovascular Association-HX Fund; Department of Nephrology, The Third Affiliated hospital of Southern Medical university, Guangzhou, China., Chinese Cardiovascular Association-HX Fund | IgA nephropathy | | | | |
NCT04263922: Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3 |
|
|
| Recruiting | 4 | 466 | RoW | Huaiqihuang granules, B12000050755, Valsartan capsule, H20030638 | The First Affiliated Hospital of Dalian Medical University, Huazhong University of Science and Technology, LinkDoc Technology (Beijing) Co. Ltd. | Renal Insufficiency, Chronic | 10/25 | 03/26 | | |
NCT02817360: NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients |
|
|
| Recruiting | 4 | 2400 | Europe, RoW | RAS-antagonist and beta-blocker up-to maximal dosages, Enalapril 40mg/d, Ramipril 10mg/d, Lisinopril 40mg/d, Cilazapril 5mg/d, Perindopril 8mg/d, Captopril 150mg/d, Spirapril 24mg/d, Quinapril 40mg/d, Trandolapril 4mg/d, Zofenopril 60mg/d, Fosinopril 40mg/d, Candesartan 32mg/d, Valsartan 320mg/d, Irbesartan 300mg/d, Losartan 150mg/d, Eprosartan 800mg/d, Bisoprolol 10mg/d, Metoprololsuccinat 200mg/d, Carvedilol 50mg/d (100mg/d if weight is > 85kg), Nebivolol 10mg/d, RAS-antagonist and beta-blocker none or at stable dose | Martin Huelsmann | Heart Diseases, Diabetes Mellitus, Type 2 | 12/25 | 12/26 | | |
NCT06035978: Determination of Drug Levels for Pharmacotherapy of Heart Failure |
|
|
| Not yet recruiting | 4 | 100 | RoW | Nebivolol, Nebilet, anatomical-therapeutic-chemical code (ATC) C07AB12, Valsartan and Sacubitril, Entresto, ATC C09DX04, Carvedilol, Dilatrend, ATC C07AG02, Bisoprolol, Concor, ATC C07AB07, Metoprolol, Betaloc ZOK, ATC C07AB02, Spironolactone, Verospiron, ATC C03DA01 | University Hospital Ostrava | Cardiovascular Diseases, Heart Failure With Reduced Ejection Fraction | 04/26 | 04/26 | | |
2015-000239-34: A clinical study to investigate the use of commonly used heart failure medicines in the prevention of heart related illnesses in patients with diabetes mellitus but without heart disease. |
|
|
| Ongoing | 3/4 | 2400 | Europe, RoW | Enalapril maleate, Ramipril, Lisinopril dihydrate, Perindopril arginine, Perindopril erbumine, Perindopril tert-butylamine, Captopril, Quinapril hydrochloride, Trandolapril, Fosinopril sodium, Candesartan cilextil, Valsartan, Irbesartan, Losartan potassium, Eprosartan mesilate, Bisoprolol fumerate, Carvedilol, Nebivilol hydrochloride, Not applicable, Tablet, , Capsule | Medizinische Universität Wien, Medical University of Vienna, Medizinische Universität Wien, | Type 2 diabetes mellitus, Type 2 diabetes, Diseases [C] - Hormonal diseases [C19] | | | | |
